Cash Flow Biocon Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
1,297.00
643.00
771.00
846.00
870.00
1,002.00
Adjustment
2,583.00
1,939.00
1,456.00
931.00
921.00
472.00
Changes In working Capital
-635.00
-501.00
-789.00
-423.00
-165.00
-29.00
Cash Flow after changes in Working Capital
3,246.00
2,081.00
1,438.00
1,353.00
1,627.00
1,446.00
Cash Flow from Operating Activities
2,953.00
1,852.00
1,176.00
1,159.00
1,283.00
1,154.00
Cash Flow from Investing Activities
-1,001.00
-14,260.00
-1,662.00
-3,651.00
-1,505.00
-702.00
Cash Flow from Financing Activities
-2,332.00
13,048.00
242.00
2,564.00
387.00
-241.00
Net Cash Inflow / Outflow
-380.00
641.00
-243.00
72.00
165.00
210.00
Opening Cash & Cash Equivalents
1,299.00
653.00
897.00
824.00
659.00
449.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
919.00
1,294.00
653.00
897.00
824.00
659.00
Compare Cash Flow Results of Biocon
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
1297.8
2399.36
-1,102.00
-45.91%
Adjustment
2583.6
212.2
2,371.00
1117.53%
Changes In working Capital
-635.2
20.42
-655.00
-3210.68%
Cash Flow after changes in Working Capital
3246.2
2631.98
615.00
23.34%
Cash Flow from Operating Activities
2953.9
2152.45
801.00
37.23%
Cash Flow from Investing Activities
-1001.6
-2080.52
1,079.00
51.86%
Cash Flow from Financing Activities
-2332.7
5.27
-2,337.00
-44363.76%
Net Cash Inflow / Outflow
-380.4
77.19
-457.00
-592.81%
Opening Cash & Cash Equivalents
1299.9
304.82
995.00
326.45%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
919.5
382.01
537.00
140.70%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 59.45% vs 57.45% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
2,953.90
1,852.50
59.45%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
